Welcome to our dedicated page for ACCURAY SEC filings (Ticker: ARAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACCURAY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACCURAY's regulatory disclosures and financial reporting.
Accuray Inc SVP tax-withholding share disposition
Accuray Inc executive Sandeep Chalke, the SVP and Chief Commercial Officer, reported a tax-related share disposition. On this Form 4, 40,000 shares of Common Stock were withheld by the company at an implied price of $0.3881 per share to cover tax obligations tied to RSU vesting.
These shares were not sold in the open market but used to satisfy tax withholding and remittance requirements in a net settlement of restricted stock units. After this transaction, Chalke directly holds 419,806 shares of Accuray Inc common stock.
The Vanguard Group files an amendment (Schedule 13G/A) reporting 0 shares of Accuray Inc common stock. The amendment states Beneficial Ownership as 0 shares and 0% of the class as of 03/13/2026 and is signed on 03/26/2026.
The filing explains that on 01/12/2026 Vanguard completed an internal realignment and its subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538; Vanguard states it no longer has beneficial ownership over securities held by those subsidiaries/divisions.
Accuray Incorporated entered into a separation agreement with Senior Vice President and Chief Commercial Officer Sandeep Chalke on March 13, 2026, ahead of his previously disclosed departure effective March 31, 2026. The agreement grants vesting of equity awards scheduled to vest on May 31, 2026, with all later equity forfeited. Mr. Chalke will receive a lump-sum cash payment of $459,000, equal to 12 months of base salary, plus a pro‑rated fiscal 2026 bonus paid on the same schedule as other executives. These benefits replace any prior severance or noncompetition payments, and the agreement, which includes a general release of claims, becomes effective after a seven‑business‑day revocation period.
Accuray SVP and COO Leonel Peralta reported equity compensation transactions involving restricted stock units and common stock. On February 28, 2026, he exercised 83,723 restricted stock units, receiving the same number of common shares at $0.00 per share. To satisfy tax withholding obligations related to this net settlement, 28,969 common shares were withheld by the company at $0.55 per share, as described in the footnote. After these transactions, Peralta directly owned 54,754 shares of Accuray common stock.
Accuray Incorporated filed a prospectus registering 7,000,516 shares of common stock for resale by selling stockholders, representing shares issuable upon exercise of warrants issued under a Loan Amendment. The prospectus states the company will not receive proceeds from resale but will receive proceeds from any cash exercise of the warrants.
The registered shares consist of 3,062,726 Super Premium, 2,187,661 Premium and 1,750,129 Penny warrant-based shares. Shares outstanding were 118,782,630 as of January 30, 2026. Exercise periods run through December 15, 2032 for the Loan Amendment warrants.
Accuray Inc. director Steven F. Mayer purchased 54,875 shares of Accuray common stock in an open-market transaction on February 20, 2026. The shares were bought at a weighted-average price of $0.5627 per share, with individual trade prices ranging from $0.5334 to $0.5897. Following this purchase, Mayer directly owns 1,545,620 shares of Accuray common stock.
Accuray Inc. director Steven F. Mayer reported open-market purchases of the company’s common stock. He bought 126,125 shares on February 18, 2026 at a weighted average price of $0.5328 per share and 69,000 shares on February 19, 2026 at a weighted average price of $0.5304 per share. These transactions increased his direct holdings to 1,490,745 shares of Accuray common stock.
Accuray Incorporated is registering 7,000,516 shares of common stock for resale by certain lending investors. These shares are issuable upon exercise of three warrant series granted in connection with an amendment to Accuray’s senior secured Financing Agreement dated December 15, 2025.
The registered shares comprise 3,062,726 shares from Super Premium Warrants at a $1.50 exercise price, 2,187,661 shares from Premium Warrants at $1.25 per share, and 1,750,129 shares from Penny Warrants at $0.01 per share. The Super Premium and Premium Warrants are exercisable from June 16, 2026 to December 15, 2032, while the Penny Warrants are exercisable from December 15, 2025 to December 15, 2032.
This is a resale registration; Accuray is not selling shares and will not receive proceeds from resales by the selling stockholders, though it would receive cash if holders choose to exercise the warrants for cash. As of January 30, 2026, Accuray had 118,782,630 common shares outstanding.
Accuray Incorporated furnished an updated investor presentation related to its fiscal 2026 second quarter earnings call. The company posted the presentation on its Investor Relations website and attached it as Exhibit 99.1. Company spokespeople plan to use this deck in discussions with analysts and investors on or after February 17, 2026.
The presentation is described as summary information and is meant to be read alongside Accuray’s other SEC filings and public announcements. The company notes that the materials are furnished under Regulation FD, are not deemed filed for liability purposes, and may be updated or revised without further obligation.